Author: [AUTHOR] Published on 11/1/2020 12:00:00 AM
Duan Liu, PhD, Assistant Professor, Mayo Clinic, Rochester, MN
Dr. Liu’s PhD thesis is “Pharmacogenetics and Drug Metabolism,” with a specific interest in the genetics of cytochrome P450 enzymes. After earning his PhD in China, he decided to pursue more clinically relevant pharmacogenomics research. When he came to the Mayo Clinic as a post‐doctoral trainee, he was fortunate to join Dr. Richard Weinshilboum’s pharmacogenomics research lab. He credits working with Dr. Weinshilboum, who introduced him to ASCPT, to learning more than pharmacogenomics and clinical pharmacology, but also more scientific thinking and research strategies.
Pharmacogenomic research drew in Dr. Liu because he believes pharmacogenomic research can be quickly translated to clinical practice and help patients. He hopes that his research will improve personalized pharmacotherapy and discovery of novel therapeutic targets.
Dr. Liu has enjoyed attending the ASCPT Annual Meeting. He feels as though the meeting has covered almost every aspect of clinical pharmacology, “leading us to the cutting edge pharmacology research and practice.” He appreciates the ability to meet with experts and talk with them face‐to‐face. He views his membership and attendance at the Annual Meeting as a great opportunity to broaden knowledge, especially for early career researchers and trainees. Dr. Liu also appreciates the volunteer opportunities provided by ASCPT. He volunteered to review meeting abstracts and manuscripts for the CPT and CTS journals. He explains that those experiences were very helpful to his academic career.
Currently, Dr. Liu is working on several pharmacogenomic research projects in Dr. Weinshilboum’s group in collaboration with psychiatrists and cardiologists at the Mayo Clinic. Those projects are trying to identify biomarkers for antidepressant treatment and heart failure pharmacotherapy.
Dr. Liu has been a member of ASCPT since 2015. He was recognized as an ASCPT Presidential Trainee in 2020.